Fifth Third Wealth Advisors LLC boosted its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 8.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,479 shares of the company's stock after acquiring an additional 2,937 shares during the quarter. Fifth Third Wealth Advisors LLC's holdings in Procter & Gamble were worth $6,491,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of PG. China Universal Asset Management Co. Ltd. increased its position in shares of Procter & Gamble by 5.5% in the first quarter. China Universal Asset Management Co. Ltd. now owns 32,001 shares of the company's stock valued at $5,192,000 after buying an additional 1,657 shares in the last quarter. Quent Capital LLC increased its position in shares of Procter & Gamble by 2.0% in the first quarter. Quent Capital LLC now owns 10,684 shares of the company's stock valued at $1,733,000 after buying an additional 206 shares in the last quarter. Bessemer Group Inc. boosted its stake in shares of Procter & Gamble by 0.3% during the first quarter. Bessemer Group Inc. now owns 784,525 shares of the company's stock valued at $127,289,000 after acquiring an additional 2,655 shares during the last quarter. Evermay Wealth Management LLC boosted its stake in shares of Procter & Gamble by 9.0% during the first quarter. Evermay Wealth Management LLC now owns 6,987 shares of the company's stock valued at $1,134,000 after acquiring an additional 574 shares during the last quarter. Finally, Crewe Advisors LLC acquired a new stake in shares of Procter & Gamble during the first quarter valued at $1,552,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Buying and Selling
In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the transaction, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 270,727 shares of company stock worth $46,014,037 in the last three months. Insiders own 0.18% of the company's stock.
Analyst Ratings Changes
PG has been the topic of a number of analyst reports. StockNews.com lowered Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Thursday, August 1st. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Dbs Bank lowered Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 1st. TD Cowen assumed coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They issued a "buy" rating and a $189.00 price target on the stock. Finally, Morgan Stanley raised their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a research note on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $177.00.
Check Out Our Latest Analysis on Procter & Gamble
Procter & Gamble Stock Performance
Procter & Gamble stock traded up $0.11 during trading hours on Tuesday, hitting $170.86. The stock had a trading volume of 2,399,270 shares, compared to its average volume of 6,657,782. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a 50-day moving average of $170.21 and a two-hundred day moving average of $168.45. The company has a market cap of $402.38 billion, a PE ratio of 29.37, a price-to-earnings-growth ratio of 3.67 and a beta of 0.42.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to analysts' expectations of $21.99 billion. During the same period in the prior year, the firm posted $1.83 EPS. Procter & Gamble's quarterly revenue was down .6% compared to the same quarter last year. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. Procter & Gamble's dividend payout ratio (DPR) is presently 69.48%.
About Procter & Gamble
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report